Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients

被引:54
作者
Soutome, Sakiko [1 ]
Otsuru, Mitsunobu [2 ]
Hayashida, Saki [2 ]
Murata, Maho [2 ]
Yanamoto, Souichi [2 ]
Sawada, Shunsuke [3 ]
Kojima, Yuka [3 ]
Funahara, Madoka [4 ]
Iwai, Hiroshi [5 ]
Umeda, Masahiro [2 ]
Saito, Toshiyuki [1 ]
机构
[1] Nagasaki Univ, Dept Oral Hlth, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan
[2] Nagasaki Univ, Dept Clin Oral Oncol, Grad Sch Biomed Sci, Nagasaki, Japan
[3] Kansai Med Univ, Dept Dent & Oral Surg, Osaka, Japan
[4] Kyushu Dent Univ, Sch Oral Hlth Sci, Fukuoka, Japan
[5] Kansai Med Univ, Dept Otolaryngol Head & Neck Surg, Osaka, Japan
关键词
BISPHOSPHONATE-RELATED OSTEONECROSIS; RISK-FACTORS; INTRAVENOUS BISPHOSPHONATES; POSITION PAPER; BREAST-CANCER; PREVENTION; PROTOCOL; THERAPY; BRONJ;
D O I
10.1038/s41598-021-96480-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tooth extraction has been avoided since it has been considered a major risk factor for medication-related osteonecrosis of the jaw (MRONJ). However, MRONJ may also develop from tooth that is an infection source. This study aimed to clarify whether tooth extraction is a risk factor for the development of MRONJ in cancer patients receiving bone-modifying agents (BMAs). This retrospective observational study included 189 patients (361 jaws) from two hospitals. The risk factors of MRONJ were identified by comparing patient characteristics between those who did and did not develop MRONJ. Furthermore, the effect of tooth extraction during BMA therapy was analyzed after adjusting for confounding factors using the propensity score matching method. MRONJ occurred in 33 patients jaws. A longer duration of BMA administration, fewer number of teeth, presence of symptoms of local infection, and infected teeth were independent risk factors of MRONJ. However, tooth extraction during BMA therapy did not increase the risk. Propensity score matching analysis showed that tooth extraction significantly lowered the risk of MRONJ development. Teeth that can be an infection source increases the risk of MRONJ, and thus, they need to be extracted even during BMA administration.
引用
收藏
页数:8
相关论文
共 25 条
[1]   Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study [J].
Asaka, Takuya ;
Ohga, Noritaka ;
Yamazaki, Yutaka ;
Sato, Jun ;
Satoh, Chiharu ;
Kitagawa, Yoshimasa .
CLINICAL ORAL INVESTIGATIONS, 2017, 21 (07) :2165-2172
[2]   Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [J].
Badros, A ;
Weikel, D ;
Salama, A ;
Goloubeva, O ;
Schneider, A ;
Rapoport, A ;
Fenton, R ;
Gahres, N ;
Sausville, E ;
Ord, R ;
Meiller, T .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :945-952
[3]   Risk Factors for Osteonecrosis of the Jaws: a Case-Control Study from the CONDOR Dental PBRN [J].
Barasch, A. ;
Cunha-Cruz, J. ;
Curro, F. A. ;
Hujoel, P. ;
Sung, A. H. ;
Vena, D. ;
Voinea-Griffin, A. E. .
JOURNAL OF DENTAL RESEARCH, 2011, 90 (04) :439-444
[4]   Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies [J].
Fehm, T. ;
Beck, V. ;
Banys, M. ;
Lipp, H. P. ;
Hairass, M. ;
Reinert, S. ;
Solomayer, E. F. ;
Wallwiener, D. ;
Krimmel, M. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (03) :605-609
[5]   Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study [J].
Hasegawa, T. ;
Hayashida, S. ;
Kondo, E. ;
Takeda, Y. ;
Miyamoto, H. ;
Kawaoka, Y. ;
Ueda, N. ;
Iwata, E. ;
Nakahara, H. ;
Kobayashi, M. ;
Soutome, S. ;
Yamada, S. I. ;
Tojyo, I. ;
Kojima, Y. ;
Umeda, M. ;
Fujita, S. ;
Kurita, H. ;
Shibuya, Y. ;
Kirita, T. ;
Komori, T. .
OSTEOPOROSIS INTERNATIONAL, 2019, 30 (01) :231-239
[6]   Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases [J].
Ikesue, Hiroaki ;
Mouri, Moe ;
Tomita, Hideaki ;
Hirabatake, Masaki ;
Ikemura, Mai ;
Muroi, Nobuyuki ;
Yamamoto, Shinsuke ;
Takenobu, Toshihiko ;
Tomii, Keisuke ;
Kawakita, Mutsushi ;
Katoh, Hironori ;
Ishikawa, Takayuki ;
Yasui, Hisateru ;
Hashida, Tohru .
SUPPORTIVE CARE IN CANCER, 2021, 29 (08) :4763-4772
[7]   Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients [J].
Kyrgidis, Athanassios ;
Vahtsevanos, Konstantinos ;
Koloutsos, Georgios ;
Andreadis, Charalampos ;
Boukovinas, Ioannis ;
Teleioudis, Zisis ;
Patrikidou, Anna ;
Triaridis, Stefanos .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) :4634-4638
[8]   Tooth Extraction in Patients Taking Intravenous Bisphosphonates: A Preventive Protocol and Case Series [J].
Lodi, Giovanni ;
Sardella, Andrea ;
Salis, Annalisa ;
Demarosi, Federica ;
Tarozzi, Marco ;
Carrassi, Antonio .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (01) :107-110
[9]   Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review [J].
Lopez-Jornet, Pia ;
Sanchez Perez, Arturo ;
Mendes, Rui Amaral ;
Tobias, Aurelio .
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2016, 44 (08) :1067-1072
[10]   A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors [J].
Manfredi, Maddalena ;
Mergoni, Giovanni ;
Goldoni, Matteo ;
Salvagni, Stefania ;
Merigo, Elisabetta ;
Meleti, Marco ;
Vescovi, Paolo .
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2017, 22 (03) :E342-E348